Aspirin after coronary. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy16

Coronary Vessels Heart Endothelium, Vascular Myocardium Blood Platelets Sinus of Valsalva Arteries Mammary Arteries Radial Artery Muscle, Smooth, Vascular Saphenous Vein Heart Ventricles Vasomotor System Tunica Intima Aorta Gastric Mucosa

Organisms3

Dogs Swine Swine, Miniature

Diseases58

Coronary Artery Disease Coronary Stenosis Coronary Disease Coronary Vasospasm Coronary Aneurysm Coronary Thrombosis Myocardial Infarction Coronary Restenosis Coronary Occlusion Myocardial Ischemia Angina, Unstable Calcinosis Hemorrhage Recurrence Thrombosis Chest Pain Cardiovascular Diseases Mucocutaneous Lymph Node Syndrome Stroke Plaque, Atherosclerotic Postoperative Complications Graft Occlusion, Vascular Diabetic Angiopathies Angina Pectoris, Variant Acute Disease Hyperemia Vascular Calcification Asthma, Aspirin-Induced Syndrome Hypercholesterolemia Gastrointestinal Hemorrhage Angina, Stable Myocardial Reperfusion Injury Hypertension Constriction, Pathologic Diabetes Complications Ventricular Dysfunction, Left Arteriosclerosis Atherosclerosis Postoperative Hemorrhage Microvascular Angina Myocardial Bridging Heart Diseases Heart Failure Death, Sudden, Cardiac Fistula Disease Models, Animal Diabetes Mellitus Dilatation, Pathologic Arterio-Arterial Fistula Cerebrovascular Disorders Embolism Myocardial Stunning Atrial Fibrillation Diabetes Mellitus, Type 2 Hyperlipidemias Arrhythmias, Cardiac Chronic Disease

Chemicals and Drugs68

Aspirin Platelet Aggregation Inhibitors Anti-Inflammatory Agents, Non-Steroidal Ticlopidine Thromboxane B2 Dipyridamole Cyclooxygenase Inhibitors Vasodilator Agents Fibrinolytic Agents Salicylates Anticoagulants Biological Markers Adenosine Cardiovascular Agents Nitroglycerin Platelet Glycoprotein GPIIb-IIIa Complex Thromboxane A2 Sodium Salicylate Heparin Hydroxymethylglutaryl-CoA Reductase Inhibitors Warfarin Nitric Oxide Purinergic P2Y Receptor Antagonists Ergonovine Thromboxanes Indomethacin C-Reactive Protein Tablets, Enteric-Coated Acetylcholine Cyclooxygenase 1 Prostaglandin-Endoperoxide Synthases Adrenergic beta-Antagonists Cholesterol, LDL Ibuprofen Thallium Radioisotopes Contrast Media Dobutamine Cholesterol Cardiotonic Agents Cyclooxygenase 2 Inhibitors Cholesterol, HDL Sirolimus Isosorbide Dinitrate Epoprostenol Creatine Kinase, MB Form Prostaglandins Papaverine Anticholesteremic Agents Lipids Bradykinin Creatine Kinase Technetium Tc 99m Sestamibi Sulfinpyrazone Lipoxins Immunoglobulin Fab Fragments Acetaminophen Pravastatin Cyclooxygenase 2 Troponin T Hypolipidemic Agents Angiotensin-Converting Enzyme Inhibitors 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid Heptanoic Acids 6-Ketoprostaglandin F1 alpha Troponin I Vasoconstrictor Agents Fibrinogen Iopamidol

Analytical, Diagnostic and Therapeutic Techniques and Equipment78

Coronary Angiography Angioplasty, Balloon, Coronary Coronary Artery Bypass Risk Factors Percutaneous Coronary Intervention Treatment Outcome Prospective Studies Follow-Up Studies Electrocardiography Stents Ultrasonography, Interventional Coronary Artery Bypass, Off-Pump Risk Assessment Myocardial Revascularization Predictive Value of Tests Platelet Function Tests Cardiac Catheterization Drug Therapy, Combination Tomography, X-Ray Computed Retrospective Studies Blood Flow Velocity Double-Blind Method Severity of Illness Index Cohort Studies Blood Pressure Myocardial Reperfusion Exercise Test Incidence Echocardiography Prognosis Multivariate Analysis Sensitivity and Specificity Case-Control Studies Chi-Square Distribution Proportional Hazards Models Logistic Models Risk Multidetector Computed Tomography Odds Ratio Tomography, Emission-Computed, Single-Photon Myocardial Perfusion Imaging Randomized Controlled Trials as Topic Bleeding Time Thrombolytic Therapy Registries Cineangiography Tomography, Spiral Computed Feasibility Studies Stroke Volume Angioscopy Perfusion Hospital Mortality Reproducibility of Results Analysis of Variance Regression Analysis Kaplan-Meier Estimate Survival Analysis Cardiopulmonary Bypass Models, Cardiovascular Angiography Prevalence Angioplasty, Balloon Disease Models, Animal Survival Rate Echocardiography, Stress Heart Arrest, Induced Magnetic Resonance Angiography Internal Mammary-Coronary Artery Anastomosis Reference Values Single-Blind Method ROC Curve Drug Administration Schedule Patient Selection Echocardiography, Doppler Postoperative Period Heart Transplantation Angiocardiography Observer Variation

Psychiatry and Psychology1

Phenomena and Processes27

Coronary Circulation Time Factors Platelet Aggregation Vasodilation Hemodynamics Blood Flow Velocity Collateral Circulation Dose-Response Relationship, Drug Blood Pressure Platelet Activation Sensitivity and Specificity Vascular Resistance Chi-Square Distribution Microcirculation Fractional Flow Reserve, Myocardial Ventricular Function, Left Risk Vasoconstriction Odds Ratio Bleeding Time Myocardial Contraction Vascular Patency Stroke Volume Regional Blood Flow Drug Resistance Drug Interactions Diastole

Disciplines and Occupations1

Information Science5

Incidence Registries Hospital Mortality Prevalence Survival Rate

Health Care41

Risk Factors Treatment Outcome Coronary Care Units Prospective Studies Follow-Up Studies Risk Assessment Predictive Value of Tests Retrospective Studies Double-Blind Method Severity of Illness Index Cohort Studies Incidence Multivariate Analysis Sensitivity and Specificity Case-Control Studies Chi-Square Distribution Proportional Hazards Models Logistic Models Risk Odds Ratio Randomized Controlled Trials as Topic Registries Sex Factors Age Factors Feasibility Studies Hospital Mortality Reproducibility of Results Analysis of Variance Regression Analysis Kaplan-Meier Estimate Survival Analysis Prevalence Primary Prevention Survival Rate Secondary Prevention Comorbidity Single-Blind Method ROC Curve Patient Selection Postoperative Period Observer Variation

Geographicals2

United States Japan

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Information Science Health Care Geographicals

Aspirin Coronary Vessels Coronary Angiography Coronary Artery Disease Coronary Circulation Angioplasty, Balloon, Coronary Coronary Stenosis Coronary Artery Bypass Coronary Disease Platelet Aggregation Inhibitors Coronary Vasospasm Coronary Aneurysm Coronary Thrombosis Myocardial Infarction Coronary Restenosis Coronary Occlusion Anti-Inflammatory Agents, Non-Steroidal Risk Factors Percutaneous Coronary Intervention Ticlopidine Treatment Outcome Coronary Care Units Prospective Studies Time Factors Follow-Up Studies Myocardial Ischemia Electrocardiography Stents Platelet Aggregation Angina, Unstable Dogs Ultrasonography, Interventional Thromboxane B2 Coronary Artery Bypass, Off-Pump Calcinosis Risk Assessment Myocardial Revascularization Dipyridamole Predictive Value of Tests Cyclooxygenase Inhibitors Vasodilator Agents Platelet Function Tests Vasodilation Hemodynamics Cardiac Catheterization Hemorrhage Drug Therapy, Combination Fibrinolytic Agents Salicylates Tomography, X-Ray Computed Retrospective Studies Heart Anticoagulants Endothelium, Vascular Myocardium Blood Flow Velocity Recurrence Thrombosis Chest Pain Blood Platelets Biological Markers Adenosine Collateral Circulation Cardiovascular Agents Dose-Response Relationship, Drug Swine Double-Blind Method Severity of Illness Index Nitroglycerin Cohort Studies Blood Pressure Myocardial Reperfusion Exercise Test Incidence Echocardiography Prognosis Cardiovascular Diseases Platelet Activation Multivariate Analysis Mucocutaneous Lymph Node Syndrome Stroke Sensitivity and Specificity Vascular Resistance Case-Control Studies Platelet Glycoprotein GPIIb-IIIa Complex Plaque, Atherosclerotic Thromboxane A2 Chi-Square Distribution Microcirculation Sodium Salicylate Fractional Flow Reserve, Myocardial Postoperative Complications Proportional Hazards Models Graft Occlusion, Vascular Logistic Models Ventricular Function, Left Risk Heparin Hydroxymethylglutaryl-CoA Reductase Inhibitors Vasoconstriction

No FAQ available that match "aspirin after coronary"